CLINICAL_TRIALS
trial_result
· 2021-08-09
Clinical Trial Update: Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma [Phase 2]
Summary
Phase 2 trial investigating palliative radiotherapy combined with anti-PD-1/PD-L1 checkpoint blockade in metastatic Merkel cell carcinoma; study terminated with…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Merkel Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-08-09